Versican Expression Is Associated With Chamber Specification, Septation, and Valvulogenesis in the Developing Mouse Heart

From the Neural Development Unit, Institute of Child Health, University College London, London, UK.

Correspondence to Dr Deborah Henderson, Neural Development Unit, Institute of Child Health, 30 Guilford St, London, WC1N 1EH, UK. E-mail dhender{at}ich.ucl.ac.uk

Abstract—The versican (PG-M) gene encodes a chondroitin sulfate proteoglycan that is nonpermissive for cell migration and appears in association with slow cell proliferation and cytodifferentiation. Using the techniques of in situ hybridization and immunocytochemistry on sectioned mouse embryos, we found that the mRNA and protein for versican show similar distributions and are expressed in a dynamic pattern during development of the heart. Versican exhibits generalized expression in the tubular heart but becomes rapidly downregulated in the atrium and exhibits higher transcript levels on the right side of the ventricular chamber than the left, before the onset of ventricular septation. Versican is expressed strongly in the trabeculated ventricular myocardium, whereas the compact proliferative zone has lower transcript abundance. It is expressed in the outer layers and on the crest of the ventricular septum and is prominent on the mesenchymal cap of the primary atrial septum. Versican is particularly strongly expressed in the endocardial cushions of the atrioventricular and outflow tract regions and in the atrioventricular, semilunar, and venous valves. This study raises the possibility that versican may be involved in specification of the ventricular chambers, in growth and fusion of the atrial and ventricular septa, and in the transformation from epithelium to mesenchyme that characterizes development of the endocardial cushions. Versican may be a key participant in cardiogenesis, responding to the many diffusible signals that mediate interactions between the developing endocardium and myocardium.

Key Words: mouse • proteoglycan • embryo • endocardial cushion • gene expression

This article has been cited by other articles:

				C. Ricciardelli, D. L. Russell, M. P. Ween, K. Mayne, S. Suwiwat, S. Byers, V. R. Marshall, W. D. Tilley, and D. J. Horsfall Formation of Hyaluronan- and Versican-rich Pericellular Matrix by Prostate Cancer Cells Promotes Cell Motility J. Biol. Chem., April 6, 2007; 282(14): 10814 - 10825. [Abstract] [Full Text] [PDF]

				N. Kamiya, H. Watanabe, H. Habuchi, H. Takagi, T. Shinomura, K. Shimizu, and K. Kimata Versican/PG-M Regulates Chondrogenesis as an Extracellular Matrix Molecule Crucial for Mesenchymal Condensation J. Biol. Chem., January 27, 2006; 281(4): 2390 - 2400. [Abstract] [Full Text] [PDF]

				F. Bouzeghrane, D. P. Reinhardt, T. L. Reudelhuber, and G. Thibault Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H982 - H991. [Abstract] [Full Text] [PDF]

				H. M. Phillips, J. N. Murdoch, B. Chaudhry, A. J. Copp, and D. J. Henderson Vangl2 Acts via RhoA Signaling to Regulate Polarized Cell Movements During Development of the Proximal Outflow Tract Circ. Res., February 18, 2005; 96(3): 292 - 299. [Abstract] [Full Text] [PDF]

				P.-S. Zheng, D. Vais, D. LaPierre, Y.-Y. Liang, V. Lee, B. L. Yang, and B. B. Yang PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation J. Cell Sci., November 15, 2004; 117(24): 5887 - 5895. [Abstract] [Full Text] [PDF]

				S. Cattaruzza, M. Schiappacassi, A. Ljungberg-Rose, P. Spessotto, D. Perissinotto, M. Morgelin, M. T. Mucignat, A. Colombatti, and R. Perris Distribution of PG-M/Versican Variants in Human Tissues and de Novo Expression of Isoform V3 upon Endothelial Cell Activation, Migration, and Neoangiogenesis in Vitro J. Biol. Chem., November 27, 2002; 277(49): 47626 - 47635. [Abstract] [Full Text] [PDF]

				S. M. Hall, A. A. Hislop, C. M. Pierce, and S. G. Haworth Prenatal Origins of Human Intrapulmonary Arteries . Formation and Smooth Muscle Maturation Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 194 - 203. [Abstract] [Full Text]

				D Perissinotto, P Iacopetti, I Bellina, R Doliana, A Colombatti, Z Pettway, M Bronner-Fraser, T Shinomura, K Kimata, M Morgelin, et al. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan Development, January 7, 2000; 127(13): 2823 - 2842. [Abstract] [PDF]

				A. Aspberg, S. Adam, G. Kostka, R. Timpl, and D. Heinegard Fibulin-1 Is a Ligand for the C-type Lectin Domains of Aggrecan and Versican J. Biol. Chem., July 16, 1999; 274(29): 20444 - 20449. [Abstract] [Full Text] [PDF]

				A. I. Olin, M. Morgelin, T. Sasaki, R. Timpl, D. Heinegard, and A. Aspberg The Proteoglycans Aggrecan and Versican Form Networks with Fibulin-2 through Their Lectin Domain Binding J. Biol. Chem., January 5, 2001; 276(2): 1253 - 1261. [Abstract] [Full Text] [PDF]

				D. J. Henderson, S. J. Conway, N. D. E. Greene, D. Gerrelli, J. N. Murdoch, R. H. Anderson, and A. J. Copp Cardiovascular Defects Associated With Abnormalities in Midline Development in the Loop-tail Mouse Mutant Circ. Res., July 6, 2001; 89(1): 6 - 12. [Abstract] [Full Text] [PDF]